Target intelligence / Profile preview

CD300 molecule like family member D (CD300LD)

Target
CD300LD
Molecular classification
Receptor, Transmembrane protein, Immunoglobulin superfamily
01

Overview

CD300 molecule like family member D (CD300LD) is a member of the CD300 family of immunoglobulin superfamily receptors, typically classified as a type I transmembrane protein found on immune cells[6][1][5]. It is predicted to function as both an activating and inhibitory receptor, participating in the modulation of immune responses and inflammatory signaling[3][5]. In mice, it has been identified as a functional virus receptor for murine norovirus, dictating species tropism[7]. CD300LD is involved in regulation of cytokine production, including interleukin-6 and tumor necrosis factor, and is implicated in a variety of immune system pathways, such as innate immunity and antigen processing[5][6]. Like other CD300 family members, its ability to bind exposed lipids on cell surfaces links it to the recognition of dead or activated immune cells, suggesting a potential role in infection, inflammation, and immune homeostasis[3][5][6]. No approved therapeutic drugs, validated clinical biomarkers, or specific safety concerns for this target in humans have been reported in the available literature.

Other names
CMRF35-like molecule 5CD300LDCD300DCMRF35A4UNQ9218/PRO28686CLM-5CMRF35-A4CLM-4CD300 antigen-like family member Dimmune receptor CD300d
02

Biological functions

Immune responseSignal transductionVirus receptor activityRegulation of interleukin-6 productionRegulation of tumor necrosis factor production
03

Disease associations

InfectionInflammationImmune system-related disorders

Beyond the preview

Go deeper on CD300 molecule like family member D (CD300LD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD300 molecule like family member D (CD300LD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call